Tumor-infiltrating B lymphocytes promote melanoma progression & resistance to therapy
PHILADELPHIA -- (Sept. 19, 2017) -- In a multi-institutional collaborative study, scientists at The Wistar Institute and the Medical University of Vienna, Austria, have identified...






